HomeCompareAVEFF vs CHD

AVEFF vs CHD: Dividend Comparison 2026

AVEFF yields 44444.44% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVEFF wins by $1.4802188700273396e+23M in total portfolio value
10 years
AVEFF
AVEFF
● Live price
44444.44%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4802188700273396e+23M
Annual income
$147,369,615,738,581,320,000,000,000,000.00
Full AVEFF calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — AVEFF vs CHD

📍 AVEFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVEFFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVEFF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVEFF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVEFF
Annual income on $10K today (after 15% tax)
$3,777,777.78/yr
After 10yr DRIP, annual income (after tax)
$125,264,173,377,794,110,000,000,000,000.00/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, AVEFF beats the other by $125,264,173,377,794,110,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVEFF + CHD for your $10,000?

AVEFF: 50%CHD: 50%
100% CHD50/50100% AVEFF
Portfolio after 10yr
$7.401094350136698e+22M
Annual income
$73,684,807,869,290,660,000,000,000,000.00/yr
Blended yield
99.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

AVEFF
No analyst data
Altman Z
-49.2
Piotroski
4/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVEFF buys
0
CHD buys
0
No recent congressional trades found for AVEFF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVEFFCHD
Forward yield44444.44%1.27%
Annual dividend / share$2.00$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%23.1%
Portfolio after 10y$1.4802188700273396e+23M$26.4K
Annual income after 10y$147,369,615,738,581,320,000,000,000,000.00$1,292.51
Total dividends collected$1.4797905017086652e+23M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: AVEFF vs CHD ($10,000, DRIP)

YearAVEFF PortfolioAVEFF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$4,455,144$4,444,444.44$10,856$156.32+$4.44MAVEFF
2$1,855,294,292$1,850,527,287.41$11,811$195.24+$1855.28MAVEFF
3$722,201,114,647$720,215,949,754.98$12,883$244.38+$722201.10MAVEFF
4$262,786,638,114,837$262,013,882,922,164.10$14,091$306.64+$262786638.10MAVEFF
5$89,382,811,928,504,960$89,101,630,225,722,080.00$15,463$385.88+$89382811928.49MAVEFF
6$28,419,510,536,946,614,000$28,323,870,928,183,110,000.00$17,033$487.17+$28419510536946.60MAVEFF
7$8,446,906,587,814,894,000,000$8,416,497,711,540,360,000,000.00$18,843$617.36+$8446906587814894.00MAVEFF
8$2,346,953,255,508,951,600,000,000$2,337,915,065,459,989,300,000,000.00$20,947$785.72+$2346953255508951552.00MAVEFF
9$609,599,312,292,179,560,000,000,000$607,088,072,308,785,000,000,000,000.00$23,419$1,004.91+$609599312292179607552.00MAVEFF
10$148,021,887,002,733,950,000,000,000,000$147,369,615,738,581,320,000,000,000,000.00$26,350$1,292.51+$1.4802188700273396e+23MAVEFF

AVEFF vs CHD: Complete Analysis 2026

AVEFFStock

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Full AVEFF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this AVEFF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVEFF vs SCHDAVEFF vs JEPIAVEFF vs OAVEFF vs KOAVEFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.